Gum disease clues: could hippo proteins be the missing link?

NCT ID NCT07759466

First seen Aug 12, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This study investigates whether proteins from the Hippo signaling pathway—known to control cell growth and bone health—are present at different levels in the gum fluid of people with healthy gums, gingivitis, or periodontitis. Researchers will collect fluid samples from 75 participants and measure these proteins along with markers of cell death and bone metabolism. The goal is to see if these proteins could serve as indicators of periodontal disease activity or progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ELISA biomarker analysis of gingival crevicular fluid
What this could lead to
If certain Hippo pathway proteins are found at different levels in gum disease, they could become biomarkers for early detection or targets for new treatments.
What could go wrong
This is a small observational study, so it can only show associations, not cause and effect. The findings may not apply to everyone or lead to practical tests.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOMARKER DISCOVERY AND VALIDATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Inonu University Faculty of Dentistry

    Malatya, 44210, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.